國立虎尾科技大學 |

Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring = An Introduction /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring/ edited by Peter B. Gahan.
其他題名:	An Introduction /
其他作者:	Gahan, Peter B.
面頁冊數:	XIX, 471 p. 59 illus., 39 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Medicine. -
電子資源:	https://doi.org/10.1007/978-94-017-9168-7
ISBN:	9789401791687

Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring = An Introduction /
Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment MonitoringAn Introduction /[electronic resource] :edited by Peter B. Gahan. - 1st ed. 2015. - XIX, 471 p. 59 illus., 39 illus. in color.online resource. - Advances in Predictive, Preventive and Personalised Medicine,52211-3495 ;. - Advances in Predictive, Preventive and Personalised Medicine,8.

Part I. BACKGROUND -- CHAPTER 1 Introduction - Brief History and the present and future status of CNAPS -- CHAPTER 2 The biology of CNAPS -- Part II. METHODOLOGY -- CHAPTER 3 Pre-analytical requirements for analysing nucleic acids from blood -- CHAPTER 4. Circulating DNA and miRNA isolation -- CHAPTER 5 Detection of genetic alterations by nucleic acid analysis: use of pcr and mass spectroscopy-based methods -- CHAPTER 6 Genomic approaches to the analysis of cell free nucleic acids -- Part III APPLICATIONS -- CHAPTER 7 CNAPS and General Medicine -- CHAPTER 8 Fetal CNAPS – DNA/RNA -- CHAPTER 9 Circulating nucleic acids and Diabetes mellitus -- CHAPTER 10 Extracellular nucleic acids and cancer -- CHAPTER 11 Other bodily fluids as non-invasive sources of Cell-free DNA/RNA -- CHAPTER 12 CNAPS in therapy monitoring -- Part IV OTHER ASPECTCS -- CHAPTER 13 Quality Assurance -- CHAPTER 14 Societal Aspects: Ethics.

DNA and RNA fractions can be isolated from a variety of body fluids including whole blood, serum, plasma, urine, saliva and cerebrospinal fluid from both patients and healthy individuals. Such isolates can be exploited in the early detection of clinical disorders, stratification of patients for treatment, treatment monitoring and clinical follow-up. In addition, the use in fetal medicine allows the early detection of fetal sex, Rh factor and aneuploid disorders as well as following both fetal and premature born infant development. This volume is intended as a primer for those who are interested in entering the field of circulating nucleic acids. The areas covered in this volume include: · Background and general biology of circulating nucleic acids · Methodology · Applications of circulating nucleic acids · Quality Assurance · Ethics.

ISBN: 9789401791687

Standard No.: 10.1007/978-94-017-9168-7doiSubjects--Topical Terms:

644133
Medicine.

LC Class. No.: R-RZ

Dewey Class. No.: 610

Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring = An Introduction /
LDR:03283nam a22004095i 4500 001 962923
003 DE-He213
005 20200706183342.0
007 cr nn 008mamaa
008 201211s2015 ne | s |||| 0|eng d
020 $a 9789401791687 $9 978-94-017-9168-7
024 7 $a 10.1007/978-94-017-9168-7 $2 doi
035 $a 978-94-017-9168-7
050 4 $a R-RZ
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MBGR $2 thema
082 0 4 $a 610 $2 23
245 1 0 $a Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring $h [electronic resource] : $b An Introduction / $c edited by Peter B. Gahan.
250 $a 1st ed. 2015.
264 1 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2015.
300 $a XIX, 471 p. 59 illus., 39 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Advances in Predictive, Preventive and Personalised Medicine, $x 2211-3495 ; $v 5
505 0 $a Part I. BACKGROUND -- CHAPTER 1 Introduction - Brief History and the present and future status of CNAPS -- CHAPTER 2 The biology of CNAPS -- Part II. METHODOLOGY -- CHAPTER 3 Pre-analytical requirements for analysing nucleic acids from blood -- CHAPTER 4. Circulating DNA and miRNA isolation -- CHAPTER 5 Detection of genetic alterations by nucleic acid analysis: use of pcr and mass spectroscopy-based methods -- CHAPTER 6 Genomic approaches to the analysis of cell free nucleic acids -- Part III APPLICATIONS -- CHAPTER 7 CNAPS and General Medicine -- CHAPTER 8 Fetal CNAPS – DNA/RNA -- CHAPTER 9 Circulating nucleic acids and Diabetes mellitus -- CHAPTER 10 Extracellular nucleic acids and cancer -- CHAPTER 11 Other bodily fluids as non-invasive sources of Cell-free DNA/RNA -- CHAPTER 12 CNAPS in therapy monitoring -- Part IV OTHER ASPECTCS -- CHAPTER 13 Quality Assurance -- CHAPTER 14 Societal Aspects: Ethics.
520 $a DNA and RNA fractions can be isolated from a variety of body fluids including whole blood, serum, plasma, urine, saliva and cerebrospinal fluid from both patients and healthy individuals. Such isolates can be exploited in the early detection of clinical disorders, stratification of patients for treatment, treatment monitoring and clinical follow-up. In addition, the use in fetal medicine allows the early detection of fetal sex, Rh factor and aneuploid disorders as well as following both fetal and premature born infant development. This volume is intended as a primer for those who are interested in entering the field of circulating nucleic acids. The areas covered in this volume include: · Background and general biology of circulating nucleic acids · Methodology · Applications of circulating nucleic acids · Quality Assurance · Ethics.
650 0 $a Medicine. $3 644133
650 0 $a Health promotion. $3 565089
650 0 $a Cancer research. $3 1253664
650 0 $a Nucleic acids. $3 788506
650 0 $a Medicinal chemistry. $3 1253747
650 1 4 $a Biomedicine, general. $3 1253757
650 2 4 $a Health Promotion and Disease Prevention. $3 593964
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Nucleic Acid Chemistry. $3 716485
650 2 4 $a Medicinal Chemistry. $3 668872
700 1 $a Gahan, Peter B. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 782119
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789401791670
776 0 8 $i Printed edition: $z 9789401791694
776 0 8 $i Printed edition: $z 9789402402179
830 0 $a Advances in Predictive, Preventive and Personalised Medicine, $x 2211-3495 ; $v 8 $3 1253856
856 4 0 $u https://doi.org/10.1007/978-94-017-9168-7
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)